[HTML][HTML] Luteolin, a flavonoid, as an anticancer agent: A review
Many food-derived phytochemicals and their derivatives represent a cornucopia of new anti-
cancer compounds. Luteolin (3, 4, 5, 7-tetrahydroxy flavone) is a flavonoid found in different …
cancer compounds. Luteolin (3, 4, 5, 7-tetrahydroxy flavone) is a flavonoid found in different …
[PDF][PDF] Potential targets for prevention of colorectal cancer: a focus on PI3K/Akt/mTOR and Wnt pathways
AK Pandurangan - Asian Pacific journal of cancer …, 2013 - pdfs.semanticscholar.org
Colorectal cancer (CRC) is one of the most common cancers in many parts of the world. Its
development is a multi-step process involving three distinct stages, initiation that alters the …
development is a multi-step process involving three distinct stages, initiation that alters the …
[HTML][HTML] Luteolin induces apoptotic cell death via antioxidant activity in human colon cancer cells
KA Kang, MJ Piao, YS Ryu… - International …, 2017 - spandidos-publications.com
The present study determined whether luteolin induces HT-29 colon cancer cell death
through an antioxidant effect such as the activation of antioxidant enzymes. Luteolin …
through an antioxidant effect such as the activation of antioxidant enzymes. Luteolin …
Polyphenols in colorectal cancer: current state of knowledge including clinical trials and molecular mechanism of action
Polyphenols have been reported to have wide spectrum of biological activities including
major impact on initiation, promotion, and progression of cancer by modulating different …
major impact on initiation, promotion, and progression of cancer by modulating different …
[HTML][HTML] Colorectal carcinogenesis: Insights into the cell death and signal transduction pathways: A review
A kumar Pandurangan, T Divya, K Kumar… - World journal of …, 2018 - ncbi.nlm.nih.gov
Colorectal carcinogenesis (CRC) imposes a major health burden in developing countries. It
is the third major cause of cancer deaths. Despite several treatment strategies, novel drugs …
is the third major cause of cancer deaths. Despite several treatment strategies, novel drugs …
Antitumor activity of Portulaca oleracea L. polysaccharides against cervical carcinoma in vitro and in vivo
R Zhao, X Gao, Y Cai, X Shao, G Jia, Y Huang… - Carbohydrate …, 2013 - Elsevier
Portulaca oleracea L. has been used as folk medicine in different countries to treat different
ailments in humans. P. oleracea L. polysaccharide (POL-P), extracted from P. oleracea L., is …
ailments in humans. P. oleracea L. polysaccharide (POL-P), extracted from P. oleracea L., is …
Luteolin, a bioflavonoid inhibits colorectal cancer through modulation of multiple signaling pathways: a review
AK Pandurangan, NM Esa - Asian Pacific Journal of Cancer …, 2014 - koreascience.kr
Abstract Luteolin, 3', 4', 5, 7-tetrahydroxyflavone, belongs to a group of naturally occurring
compounds called flavonoids that are found widely in the plant kingdom. It possesses many …
compounds called flavonoids that are found widely in the plant kingdom. It possesses many …
Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice
AK Pandurangan, N Mohebali… - Drug design …, 2015 - Taylor & Francis
Gallic acid (GA) is a polyhydroxy phenolic compound that has been detected in various
natural products, such as green tea, strawberries, grapes, bananas, and many other fruits. In …
natural products, such as green tea, strawberries, grapes, bananas, and many other fruits. In …
[HTML][HTML] Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin …
D Lin, G Kuang, J Wan, X Zhang, H Li… - Oncology …, 2017 - spandidos-publications.com
The metastasis of breast cancer is associated with dismal prognosis and high mortality due
to the lack of effective treatment. Luteolin, a natural flavonoid compound, has been shown to …
to the lack of effective treatment. Luteolin, a natural flavonoid compound, has been shown to …
Antitumor activity of luteolin in human colon cancer SW620 cells is mediated by the ERK/FOXO3a signaling pathway
The aim of this study was to investigate the mechanism of the anticancer activity of luteolin in
metastatic human colon cancer SW620 cells. Luteolin dose-dependently reduced the …
metastatic human colon cancer SW620 cells. Luteolin dose-dependently reduced the …